Commission Decision of 14 December 2010 appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency
Date: 2010-12-14
Institutions: European Commission
Subjects: European Commission, European Medicines Agency, appointment of staff, board of directors








C_2010340EN.01001701.xml










15.12.2010   


EN


Official Journal of the European Union


C 340/17





COMMISSION DECISION
of 14 December 2010
appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency
2010/C 340/10
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (1), and in particular Article 65 thereof,
Whereas:






(1)


Pursuant to Article 65 of Regulation (EC) No 726/2004, the Management Board of the European Medicine Agency (hereinafter ‘the Agency’) is to include two representatives of the Commission.










(2)


Due to reallocation of competences within the Commission, it is necessary to appoint two new members of the Management Board of the Agency from the Directorate-General for Health and Consumers and from the Directorate-General for Enterprise and Industry and two alternates who will replace the members in their absence and vote on their behalf,




HAS DECIDED AS FOLLOWS:
Article 1
The representatives of the Commission to the Management Board of the European Medicines Agency shall be the persons occupying the following positions and exercising the following functions:






 


From the Directorate-General for Health and Consumers:






(a)


Director-General of the Directorate-General for Health and Consumers.














 


The alternate representative shall be the person occupying the following position and exercising the following functions:






(b)


Director heading the Directorate which is responsible for the authorisation of medicinal products on the basis of the work program of the Directorate-General for Health and Consumers.














 


From the Directorate-General for Enterprise and Industry:






(c)


Director heading the Directorate which is responsible for pharmaceuticals on the basis of the work program of the Directorate-General for Enterprise and Industry.














 


The alternate representative shall be the person occupying the following position and exercising the following functions:






(d)


Head of Unit heading the Unit responsible for pharmaceuticals on the basis of the work program of the Directorate-General for Enterprise and Industry.








Article 2
This Decision shall apply to the persons occupying, including on a temporary basis, the positions referred to in Article 1 at the date of adoption of this Decision, or to any successor of those persons in those positions.
Article 3
The Director-Generals of the Directorate-General for Health and Consumers and the Directorate-General for Enterprise and Industry shall inform the President of the Management Board and the Executive Director of the Agency of the names of the persons occupying the positions referred to in Article 1, and any changes thereof.

Done at Brussels, 14 December 2010.


For the Commission

John DALLI

Member of the Commission





(1)  OJ L 136, 30.4.2004, p. 1.